Prudential Financial
BNTX icon

Prudential Financial’s BioNTech BNTX Stock Holding History

Prudential Financial’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,358
Closed -$218K – 2702
2024
Q1 		$218K Sell
2,358
-684
-22% -$65.6K ﹤0.01% 2446
2023
Q4 		$321K Buy
+3,042
New +$307K ﹤0.01% 2294
2022
Q1 		– Sell
-8,611
Closed -$2M – 2613
2021
Q4 		$2M Sell
8,611
-14,500
-63% -$3.97M ﹤0.01% 1540
2021
Q3 		$6.31M Sell
23,111
-500
-2% -$159K 0.01% 888
2021
Q2 		$5.29M Buy
23,611
+1,400
+6% +$264K 0.01% 1002
2021
Q1 		$2.42M Buy
+22,211
New +$2.36M ﹤0.01% 1360

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prudential Financial's BNTX Position: Q2 2024 in Review

Prudential Financial sold out of BioNTech (BNTX) in Q2 2024, closing a stake of 2,358 shares — an estimated $218K sold.

Prudential Financial first reported a position in BNTX in Q1 2021 and held it in 6 quarters. The position peaked at $6.31M in Q3 2021. 286 funds tracked by Wall St. Rank hold BNTX as of Q2 2024.

  • Prudential Financial reported no remaining BioNTech position as of Q2 2024 after selling out during the quarter.
  • Prudential Financial sold 2,358 BioNTech shares in Q2 2024, an estimated $218K.
  • Prudential Financial first reported a position in BioNTech in Q1 2021 and held it in 6 quarters.
  • Prudential Financial's BioNTech position peaked at $6.31M in Q3 2021.
  • 286 funds tracked by Wall St. Rank held BioNTech as of Q2 2024.

Based on Prudential Financial's 13F filing for Q2 2024, filed 13 Aug 2024.